Bactana Corp. Company
Bactana is a global development stage company at the forefront of identifying and isolating molecules expressed from commensal anaerobic bacteria found in an animal's microbiome. Bactana develops therapies for pets to treat metabolic conditions like prediabetes, diabetes, and other diseases while also developing sustainable products to reduce the use of antibiotics and natural resources during livestock production. It was founded in 2017 and is headquartered in Farmington, Connecticut.
Industry:
Geroscience
Headquarters:
Farmington, Connecticut, United States
Zip:
1-10
Founded Date:
2017-01-01
Employees Number:
1-10
Acquisitions Number:
5
Investors Number:
2003000
Total Funding:
$1M to $10M
Estimated Revenue:
$1M to $10M
Last Funding Date:
Debt Financing
Last Funding Type:
john@bactana.com
Register and Claim Ownership